
Core Insights - Adient reported $3.56 billion in revenue for the quarter ended September 2024, a year-over-year decline of 4.5%, with an EPS of $0.68 compared to $0.51 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $3.48 billion, resulting in a surprise of +2.25%, while the EPS also surpassed expectations by +21.43% [1] Revenue Performance by Region - Net Sales in Asia reached $765 million, exceeding the estimated $715.33 million, reflecting a year-over-year increase of +2.3% [3] - Net Sales in the Americas were reported at $1.72 billion, slightly below the average estimate of $1.74 billion, indicating a year-over-year decline of -6.3% [3] - Net Sales in EMEA amounted to $1.10 billion, surpassing the estimated $1.07 billion, but showing a year-over-year decrease of -6.1% [3] - Net Sales from Eliminations were reported at -$25 million, worse than the estimated -$23.63 million, representing a year-over-year change of -10.7% [3] Stock Performance - Adient's shares have returned -9.1% over the past month, contrasting with the Zacks S&P 500 composite's +4.9% change [4] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [4]